Eric M. Reiman, Pierre Tariot, Jessica Langbaum on Cognitive Decline Trips Up API Trials of BACE Inhibitor
COMMENT We were extremely disappointed to learn about the early worsening of some cognitive measures in our research participants and the need to discontinue testing of the BACE1 inhibitor CNP520 (umibecestat) in our Alzheimer’s Prevention Initiative (API) ...